SCHEMBL387663

SCHEMBL387663

NCCc1c[nH]c2ccc(F)cc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPO P05164 11/20 1.00
HTR2A P28223 6/20 1.00
TRPM8 Q7Z2W7 3/20 1.00
HTR1A P08908 2/20 0.97
KMT2A Q03164 1/20 0.97
SLC6A4 P31645 3/20 0.73
GPR84 Q9NQS5 1/20 0.69
HTR1D P28221 2/20 0.66
HTR3E A5X5Y0 1/20 0.66
HTR3B O95264 1/20 0.66
CYP1A2 P05177 1/20 0.66
CYP3A4 P08684 1/20 0.66
CYP2D6 P10635 1/20 0.66
CYP2C9 P11712 1/20 0.66
TSHR P16473 1/20 0.66
DRD1 P21728 1/20 0.66
HTR1B P28222 1/20 0.66
HTR2C P28335 1/20 0.66
HTR1E P28566 1/20 0.66
HTR1F P30939 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28364393 1.00 MPO (1.00) MPOHTR2ATRPM8HTR1AKMT2A
SCHEMBL30155707 1.00 MPO (1.00) MPOHTR2ATRPM8HTR1AKMT2A
Hydrochloric Acid SCHEMBL1967285 0.98 HTR1A (1.00) MPOHTR2ATRPM8HTR1AKMT2A
Hydrochloric Acid SCHEMBL30487836 0.98 HTR1A (1.00) MPOHTR2ATRPM8HTR1AKMT2A
Methane SCHEMBL7805062 0.98 MPO (0.97) MPOHTR2ATRPM8HTR1AKMT2A
Cyanide SCHEMBL28693179 0.95 MPO (0.91) MPOHTR2ATRPM8HTR1AKMT2A
SCHEMBL3702815 0.90 MPO (1.00) MPOHTR2ATRPM8HTR1AKMT2A
SCHEMBL3705476 0.89 MPO (1.00) MPOHTR2ATRPM8HTR1AKMT2A
SCHEMBL2537905 0.87 MPO (0.77) MPOHTR2ATRPM8HTR1AKMT2A
SCHEMBL2403830 0.87 MPO (1.00) MPOHTR2ATRPM8HTR1AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 294 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250354108-A1 METHODS FOR PRODUCING MONOTERPENE INDOLE ALKALOIDS UNIV DANMARKS TEKNISKE (DK) 2025-11-20 US claimed
CN-115850269-A Tetrahydro-beta-carboline compound and preparation method and application thereof 南京工业大学 2023-03-28 CN claimed
CN-112010838-A Naphthalimide-indole derivative-based intracellular reticulum fluorescent probe and application thereof 中国科学院化学研究所 2020-12-01 CN claimed
US-20120122948-A1 3-ALKYL-5-FLUOROINDOLE DERIVATIVES AS MYELOPEROXIDASE INHIBITORS UNIVERSITE LIBRE DE BEUXELLES (BE) 2012-05-17 US claimed
WO-2010136546-A1 3-ALKYL-5-FLUOROINDOLE DERIVATIVES AS MYELOPEROXIDASE INHIBITORS Université Libre de Bruxelles (BE) 2010-12-02 WO claimed
EP-1568770-A2 Pharmaceutical use of compounds which bind to a mammalian \"trace amine\" receptor Oregon Health & Science University (US) 2005-08-31 EP claimed
US-20040072187-A1 Novel mammalian receptor genes and uses OREGON HEALTH & SCIENCE UNIVERSITY 2004-04-15 US claimed
EP-1319070-A2 MAMMALIAN RECEPTOR GENES AND USES Oregon Health & Science University (US) 2003-06-18 EP claimed
WO-2002022801-A2 MAMMALIAN RECEPTOR GENES AND USES OREGON HEALTH & SCIENCE UNIVERSITY (US) 2002-03-21 WO claimed
US-3930948-A ENZYMATIC METHOD FOR PRODUCING AROMATIC ETHYLAMINES AJINOMOTO CO., INC. (JA) 1976-01-06 US claimed
WO-2025264058-A9 NOVEL COMPOUND AND USE THEREOF 주식회사 진큐어 2026-02-26 WO disclosed
US-20250354108-A1 METHODS FOR PRODUCING MONOTERPENE INDOLE ALKALOIDS UNIV DANMARKS TEKNISKE (DK) 2025-11-20 US disclosed
US-20250326719-A1 FUSED BICYCLIC ALKYLENE LINKED IMIDODICARBONIMIDIC DIAMIDES, METHODS FOR SYNTHESIS, AND USES IN THERAPY NOVATARG INC (US) 2025-10-23 US disclosed
US-20250276066-A1 METHODS, COMPOSITIONS AND COMPOUNDS FOR TREATING AGE-RELATED DISEASES AND CONDITIONS GERO PTE LTD (SG) 2025-09-04 US disclosed
US-12371404-B2 Fused bicyclic alkylene linked imidodicarbonimidic diamides, methods for synthesis, and uses in therapy NOVATARG, INC. (US) 2025-07-29 US disclosed
US-4806551-A PLATELET AGGREGATION-INHIBITOR AND THROMBOXAN A2-ANTAGONIST BAYER AKTIENGESELLSCHAFT (DE) 1989-02-21 US disclosed
EP-0242767-A2 N-dihydroindolyl ethyl-sulfon amides BAYER AG (DE) 1987-10-28 EP disclosed
EP-0187122-A2 1,3,4-Trisubstituted azacycloalkanes or azacycloalkenes CIBA-GEIGY AG (CH) 1986-07-09 EP disclosed
US-4190657-A ANTI-ANOXIA AND PSYCHOTROPIC ACTIVITY SYNTHELABO (FR) 1980-02-26 US disclosed
US-4146643-A HALO-, HYDROXY-, ALKYL-, AND ALKOXY-VINCAMINE DERIVATIVES SANDOZ LTD. (CH) 1979-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250326719-A1 FUSED BICYCLIC ALKYLENE LINKED IMIDODICARBONIMIDIC DIAMIDES, METHODS FOR SYNTHESIS, AND USES IN THERAPY SLC16A7, SLC16A1, HADHB MPO 3308/4885HTR2A 3926/4885TRPM8 647/4885
US-20120122948-A1 3-ALKYL-5-FLUOROINDOLE DERIVATIVES AS MYELOPEROXIDASE INHIBITORS MPO, SERPINB1, MAOA MPO 1/4885HTR2A 145/4885TRPM8 3657/4885
US-12371404-B2 Fused bicyclic alkylene linked imidodicarbonimidic diamides, methods for synthesis, and uses in therapy SLC16A7, SLC16A1, HADHB MPO 3308/4885HTR2A 3926/4885TRPM8 647/4885
US-20250276066-A1 METHODS, COMPOSITIONS AND COMPOUNDS FOR TREATING AGE-RELATED DISEASES AND CONDITIONS UPF1, NLN, BRCA1 MPO 4842/4885HTR2A 3360/4885TRPM8 3561/4885
US-20250354108-A1 METHODS FOR PRODUCING MONOTERPENE INDOLE ALKALOIDS INMT, KARS1, MIA3 MPO 4073/4885HTR2A 2339/4885TRPM8 3824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.